Sequoia Capital invests $12mn in Paras Pharma

Venture capital firm Sequoia Capital India today said it has invested $12 million in OTC and personal care company Paras Pharmaceuticals.

Ahmedabad-based Paras Pharmaceuticals has a portfolio of 15 successful brands, including Moov and DCold which are among the top 10 Indian OTC brands.

Sequoia Capital India will help us in achieving our aim of taking our brands and business to the next level. We believe that Sequoia Capital India and Actis can provide us with sound advice as well as assist us in strengthening our portfolio
and brands, Girish Patel, CEO of Paras Pharma, said.